Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 6:41 pm Sale | 2025-03-31 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 2,862,448 5.600% | -1,286,414 (-31.01%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | Nantahala Capital Management, LLC | 5,459,278 9.990% | 936,094 (+20.70%) | Filing History |
| 2025-05-15 08:07 am Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | RTW Investments, LP | 4,245,476 8.300% | 4,245,476 (New Position) | Filing History |
| 2025-05-15 06:05 am Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | Balyasny Asset Management L.P. | 4,787,975 9.300% | 842,048 (+21.34%) | Filing History |
| 2025-05-02 5:00 pm Sale | 2025-03-31 | 13G | Verastem, Inc. VSTM | Soleus Private Equity Fund III, L.P. | 935,819 1.800% | -3,058,810 (-76.57%) | Filing History |
| 2025-04-30 11:13 am Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | The Vanguard Group | 2,430,110 4.710% | 118,596 (+5.13%) | Filing History |
| 2025-04-24 11:26 am Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | BlackRock Inc. BLK | 2,518,642 4.900% | 283,943 (+12.71%) | Filing History |
| 2025-03-21 5:05 pm Unchanged | 2024-12-31 | 13G | Verastem, Inc. VSTM | BARCLAYS PLC | 3,949,801 8.870% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | Nantahala Capital Management, LLC | 4,523,184 9.990% | 470,980 (+11.62%) | Filing History |
| 2025-02-14 4:26 pm Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 4,706,551 9.990% | 427,030 (+9.98%) | Filing History |
| 2025-02-14 4:22 pm Sale | 2024-12-31 | 13G | Verastem, Inc. VSTM | Alyeska Investment Group, L.P. | 1,000,000 2.100% | -1,859,954 (-65.03%) | Filing History |
| 2025-02-14 2:26 pm Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | BARCLAYS PLC | 3,949,801 8.870% | 3,949,801 (New Position) | Filing History |
| 2025-02-14 07:27 am Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | Balyasny Asset Management L.P. | 3,945,927 8.870% | 3,945,927 (New Position) | Filing History |
| 2025-02-13 12:32 pm Sale | 2024-12-31 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management, LLC | 2,203,333 4.800% | -440,287 (-16.65%) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | Soleus Capital Master Fund, L.P. | 3,350,692 7.300% | 1,925,058 (+135.03%) | Filing History |
| 2025-01-31 10:08 am Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | The Vanguard Group | 2,311,514 5.190% | 2,311,514 (New Position) | Filing History |
| 2025-01-21 11:57 am Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | Orin Hirschman | 2,717,827 6.100% | 2,717,827 (New Position) | Filing History |
| 2024-11-14 6:25 pm Purchase | 2024-09-30 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 4,148,862 9.900% | 2,619,747 (+171.32%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Verastem, Inc. VSTM | Nantahala Capital Management, LLC | 4,052,204 9.990% | 4,052,204 (New Position) | Filing History |
| 2024-11-14 4:38 pm Purchase | 2024-09-30 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% | 1,662,119 (+63.50%) | Filing History |